UBS Group’s Moleculin Biotech MBRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.41K | Buy |
+7,989
| New | +$2.41K | ﹤0.01% | 8149 |
|
|
2025
Q1 | – | Sell |
-8,939
| Closed | -$15.2K | – | 9104 |
|
|
2024
Q4 | $15.2K | Buy |
+8,939
| New | +$15.2K | ﹤0.01% | 6822 |
|
|
2023
Q4 | – | Sell |
-13
| Closed | -$85 | – | 8364 |
|
|
2023
Q3 | $85 | Buy |
+13
| New | +$85 | ﹤0.01% | 7772 |
|
|
2023
Q1 | – | Sell |
-750
| Closed | -$11.9K | – | 8782 |
|
|
2022
Q4 | $11.9K | Buy |
750
+54
| +8% | +$858 | ﹤0.01% | 7141 |
|
|
2022
Q3 | $11K | Buy |
696
+586
| +533% | +$9.26K | ﹤0.01% | 7206 |
|
|
2022
Q2 | $2K | Buy |
+110
| New | +$2K | ﹤0.01% | 8538 |
|
|
2021
Q4 | – | Sell |
-94
| Closed | -$4K | – | 9274 |
|
|
2021
Q3 | $4K | Buy |
94
+23
| +32% | +$979 | ﹤0.01% | 7503 |
|
|
2021
Q2 | $4K | Buy |
+71
| New | +$4K | ﹤0.01% | 7566 |
|
|
2021
Q1 | – | Sell |
-408
| Closed | -$29K | – | 8108 |
|
|
2020
Q4 | $29K | Sell |
408
-287
| -41% | -$20.4K | ﹤0.01% | 5655 |
|
|
2020
Q3 | $51K | Buy |
695
+167
| +32% | +$12.3K | ﹤0.01% | 4785 |
|
|
2020
Q2 | $46K | Buy |
528
+151
| +40% | +$13.2K | ﹤0.01% | 5084 |
|
|
2020
Q1 | $21K | Buy |
377
+157
| +71% | +$8.75K | ﹤0.01% | 5560 |
|
|
2019
Q4 | $18K | Buy |
220
+104
| +90% | +$8.51K | ﹤0.01% | 5877 |
|
|
2019
Q3 | $12K | Buy |
116
+113
| +3,767% | +$11.7K | ﹤0.01% | 6086 |
|
|
2019
Q2 | $0 | Buy |
+3
| New | – | ﹤0.01% | 7066 |
|
|
2019
Q1 | – | Sell |
-9
| Closed | -$1K | – | 6999 |
|
|
2018
Q4 | $1K | Sell |
9
-33
| -79% | -$3.67K | ﹤0.01% | 6968 |
|
|
2018
Q3 | $6K | Buy |
+42
| New | +$6K | ﹤0.01% | 6482 |
|
|
2018
Q1 | – | Sell |
-22
| Closed | -$4K | – | 6988 |
|
|
2017
Q4 | $4K | Hold |
22
| – | – | ﹤0.01% | 6490 |
|
|
2017
Q3 | $5K | Sell |
22
-129
| -85% | -$29.3K | ﹤0.01% | 6300 |
|
|
2017
Q2 | $26K | Buy |
151
+78
| +107% | +$13.4K | ﹤0.01% | 5175 |
|
|
2017
Q1 | $7K | Buy |
73
+49
| +204% | +$4.7K | ﹤0.01% | 5892 |
|
|
2016
Q4 | $5K | Sell |
24
-4
| -14% | -$833 | ﹤0.01% | 6261 |
|
|
2016
Q3 | $14K | Buy |
28
+16
| +133% | +$8K | ﹤0.01% | 5652 |
|
|
2016
Q2 | $8K | Buy |
+12
| New | +$8K | ﹤0.01% | 6004 |
|